Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Analytical and Bioanalytical Chemistry|August 18, 2012
Analysis of cyclosporin A, tacrolimus, sirolimus, and everolimus in dried blood spot samples using liquid chromatography tandem mass spectrometryJ C G den Burger, A J Wilhelm, A Chahbouni, et al.
Alimentary Pharmacology & Therapeutics|September 1, 2005
On the limitation of 6-tioguaninenucleotide monitoring during tioguanine treatmentN K H de Boer, P de Graaf, A J Wilhelm, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 17, 2023
A new approach to drug intravenous compatibility research: the case of obstetric parenteral drugsA F Leeuwerik, L N van Merendonk, M A de Boer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2015
Lupus-Prone Mice Resist Immune Regulation and Transplant Tolerance InductionB T Stocks, A J Wilhelm, C S Wilson, et al.
Basic Research in Cardiology|July 1, 1988
Effect of sarcomere length and filament lattice spacing on force development in skinned cardiac and skeletal muscle preparations from the rabbitE L de Beer, R L Grundeman, A J Wilhelm, et al.
Head & Neck|June 16, 2001
Radioimmunotherapy in patients with head and neck squamous cell carcinoma: initial experienceD R Colnot, J J Quak, J C Roos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Biodistribution of radiolabeled monoclonal antibody E48 IgG and F(ab')2 in patients with head and neck cancerR de Bree, J C Roos, J J Quak, et al.
Therapeutic Drug Monitoring|March 27, 2003
Toxicokinetics of nortriptyline and amitriptyline: two case reportsE J F Franssen, P W A Kunst, P M Bet, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 6, 2001
Evaluation of limited blood sampling in a preceding 99mTc-labeled diagnostic study to predict the pharmacokinetics and myelotoxicity of 186Re-cMAb U36 radioimmunotherapyD R Colnot, A J Wilhelm, J Cloos, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 4, 2001
Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neckD R Colnot, J J Quak, J C Roos, et al.
Pageof 3